» Articles » PMID: 16884345

Pharmacokinetic Profile of the Isoflavone Puerarin After Acute and Repeated Administration of a Novel Kudzu Extract to Human Volunteers

Overview
Date 2006 Aug 4
PMID 16884345
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: This study was undertaken to assess the pharmacokinetic profile of puerarin, the major isoflavone found in a kudzu (Pueraria lobata) extract after acute and repeated administration.

Methods: Participants were given either single or repeated doses of kudzu extract, and blood samples were collected for either 8 or 72 hours for subsequent pharmacokinetic analyses of puerarin.

Results: Using WinNonlin pharmacokinetic data analysis software, puerarin was found to be rapidly absorbed via the oral route, reach peak levels at 2 hours, and have a half-life of approximately 4.3 hours. The elimination half-life was not significantly altered after repeated administration.

Conclusions: A formulation of kudzu extract delivers a large amount of the principal isoflavone in a rapid manner. The elimination rate constants and the mono-exponential decline in blood levels suggest that a one compartment model adequately explains how puerarin is handled by the body. Three times a day dosing is recommended as accumulation will not occur, and plasma levels remain at levels that are biologically active, even 8 hours after the last steady-state dose.

Citing Articles

The Efficacy and Safety of Multiple Dose Regimens of Kudzu () Root Extract on Bone and Cartilage Turnover and Menopausal Symptoms.

Bihlet A, Byrjalsen I, Andersen J, Simonsen S, Mundbjerg K, Helmer B Front Pharmacol. 2021; 12:760629.

PMID: 34744740 PMC: 8568880. DOI: 10.3389/fphar.2021.760629.


Using Porcine Jejunum Ex Vivo to Study Absorption and Biotransformation of Natural Products in Plant Extracts: as a Case Study.

Houriet J, Arnold Y, Pellissier L, Kalia Y, Wolfender J Metabolites. 2021; 11(8).

PMID: 34436482 PMC: 8398828. DOI: 10.3390/metabo11080541.


A single dose of kudzu extract reduces alcohol consumption in a binge drinking paradigm.

Penetar D, Toto L, Lee D, Lukas S Drug Alcohol Depend. 2015; 153:194-200.

PMID: 26048637 PMC: 4510012. DOI: 10.1016/j.drugalcdep.2015.05.025.


A standardized kudzu extract (NPI-031) reduces alcohol consumption in nontreatment-seeking male heavy drinkers.

Lukas S, Penetar D, Su Z, Geaghan T, Maywalt M, Tracy M Psychopharmacology (Berl). 2012; 226(1):65-73.

PMID: 23070022 PMC: 3562758. DOI: 10.1007/s00213-012-2884-9.


The isoflavone puerarin reduces alcohol intake in heavy drinkers: a pilot study.

Penetar D, Toto L, Farmer S, Lee D, Ma Z, Liu Y Drug Alcohol Depend. 2012; 126(1-2):251-6.

PMID: 22578529 PMC: 3430804. DOI: 10.1016/j.drugalcdep.2012.04.012.